Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Immunome Inc. (IMNM)  
$8.68 0.24 (2.69%) as of 4:30 Wed 6/25


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 87,010,000
Market Cap: 755.25(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $5.56 - $16.51
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    : 5.7
Insider 6 Months    : 13.6
Insider 3/6 Months : 19.7
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Immunome is a biopharmaceutical company utilizing a proprietary human memory B cell platform to discover and develop antibody therapeutics designed to change the way diseases are being treated. Co.'s primary focus areas are oncology and infectious disease. Co. is advancing two programs: a three-antibody cocktail (IMM-BCP-01) for potential treatment and prophylaxis of SARS-CoV-2, and an antibody (IMM-ONC-01) against interleukin 38, an immune checkpoint, for the potential treatment of various solid tumors.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 5,000 174,300 318,105 631,609
Total Buy Value $46,900 $1,370,436 $2,778,055 $5,443,256
Total People Bought 1 3 4 5
Total Buy Transactions 1 4 9 14
Total Shares Sold 0 0 17,904 17,904
Total Sell Value $0 $0 $279,296 $279,296
Total People Sold 0 0 2 2
Total Sell Transactions 0 0 2 2
End Date 2025-03-27 2024-12-24 2024-06-25 2023-06-26

   
Records found: 53
  Page 1 of 3  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Bienaime Jean Jacques   –       •      –    2025-06-03 4 B $9.38 $46,900 D/D 5,000 36,415 0.01 -4%     
   Higgins Jack Chief Scientific Officer   •       –      –    2025-03-27 4 OE $1.35 $7,020 D/D 5,200 18,729     -
   Tsai Philip Chief Technology Officer   •       –      –    2025-03-24 4 B $8.42 $103,566 D/D 12,300 33,300 0.01 9%     
   Bienaime Jean Jacques   –       •      –    2025-03-24 4 B $8.21 $57,470 D/D 7,000 23,615 0.01 9%     
   Siegall Clay B President and CEO   •       •      –    2025-01-31 4 B $7.75 $1,162,500 D/D 150,000 669,636 0.01 -14%     
   Siegall Clay B President and CEO   •       •      –    2024-11-22 4 B $9.78 $331,918 D/D 33,943 519,636 0.01 -40%     
   Siegall Clay B President and CEO   •       •      –    2024-11-21 4 B $9.54 $630,263 D/D 66,057 485,693 0.01 -37%     
   Tsai Philip Chief Technology Officer   •       –      –    2024-11-21 4 B $9.43 $198,030 D/D 21,000 21,000 0.01 -37%     
   Lechleider Robert Chief Medical Officer   •       –      –    2024-11-21 4 B $9.48 $149,800 D/D 15,805 15,805 0.01 -37%     
   Rosett Max Chief Financial Officer   •       –      –    2024-09-19 4 S $16.01 $230,224 D/D (14,380) 47,476 31%     
   Rosett Max Chief Financial Officer   •       –      –    2024-09-19 4 OE $1.05 $44,100 D/D 42,000 61,856     -
   Higgins Jack Chief Scientific Officer   •       –      –    2024-08-19 4 GD $0.00 $0 D/D 2,471 13,529     -
   Bienaime Jean Jacques   –       •      –    2024-08-16 4 B $13.94 $97,608 D/D 7,000 16,615 0.01 -19%     
   Higgins Jack Chief Scientific Officer   •       –      –    2024-08-15 4 S $13.93 $49,072 D/D (3,524) 16,000 21%     
   Higgins Jack Chief Scientific Officer   •       –      –    2024-08-15 4 OE $1.35 $26,357 D/D 19,524 19,524     -
   Bienaime Jean Jacques   –       •      –    2024-05-21 4 B $13.57 $27,140 D/D 2,000 9,615 0.01 -1%     
   Siegall Clay B President and CEO   •       •      –    2024-05-21 4 B $13.78 $281,548 D/D 20,434 419,636 0.01 -1%     
   Siegall Clay B President and CEO   •       •      –    2024-05-20 4 B $13.91 $1,106,524 D/D 79,566 399,202 0.01 6%     
   Lapetina Bob PAO and VP Finance & Corporate   •       –      –    2024-01-02 3 IO $0.00 $0 D/D 0 12,047 42%     
   Bienaime Jean Jacques Director   –       •      –    2023-11-07 3 IO $0.00 $0 D/D 0 7,615 170%     
   Barchas Isaac Director   –       •      –    2023-10-02 3 IO $0.00 $0 I/I 0 2,712,328 182%     
   Barchas Isaac Director   –       •      –    2023-10-02 3 IO $0.00 $0 D/D 0 121,680 182%     
   Siegall Clay B President and CEOOfficer   •       •      –    2023-10-02 3 IO $0.00 $0 D/D 0 150,432 182%     
   Siegall Clay B President and CEO   •       •      –    2023-10-02 4 B $5.91 $999,996 D/D 169,204 319,636 2.81 182%     
   Turner Bruce Chief Strategy Officer   •       –      –    2023-10-02 4 B $5.91 $249,993 D/D 42,300 42,300 2.74 182%     
  53 Records found
  1  2  3   
  Page 1 of 3
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us